![Applying Serum Proteins and MicroRNA as Novel Biomarkers for Early-Stage Cervical Cancer Detection | Scientific Reports Applying Serum Proteins and MicroRNA as Novel Biomarkers for Early-Stage Cervical Cancer Detection | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-65850-z/MediaObjects/41598_2020_65850_Fig1_HTML.png)
Applying Serum Proteins and MicroRNA as Novel Biomarkers for Early-Stage Cervical Cancer Detection | Scientific Reports
![Keith Siau on Twitter: "Tumour markers in clinical practice https://t.co/5BHTFBulmk https://t.co/S1WIpLRdWO" / Twitter Keith Siau on Twitter: "Tumour markers in clinical practice https://t.co/5BHTFBulmk https://t.co/S1WIpLRdWO" / Twitter](https://pbs.twimg.com/media/EmUwVZbXcAIaHnD.jpg)
Keith Siau on Twitter: "Tumour markers in clinical practice https://t.co/5BHTFBulmk https://t.co/S1WIpLRdWO" / Twitter
![Human Plasma Levels of Vascular Endothelial Growth Factor, Matrix Metalloproteinase 9, and Tissue Inhibitor of Matrix Metalloproteinase 1 and Their Applicability as Tumor Markers in Diagnoses of Cervical Cancer Based on ROC Human Plasma Levels of Vascular Endothelial Growth Factor, Matrix Metalloproteinase 9, and Tissue Inhibitor of Matrix Metalloproteinase 1 and Their Applicability as Tumor Markers in Diagnoses of Cervical Cancer Based on ROC](https://journals.sagepub.com/cms/10.1177/1073274818789357/asset/images/large/10.1177_1073274818789357-fig1.jpeg)
Human Plasma Levels of Vascular Endothelial Growth Factor, Matrix Metalloproteinase 9, and Tissue Inhibitor of Matrix Metalloproteinase 1 and Their Applicability as Tumor Markers in Diagnoses of Cervical Cancer Based on ROC
![Table I from CYFRA 21.1 in patients with cervical cancer: comparison with SCC and CEA. | Semantic Scholar Table I from CYFRA 21.1 in patients with cervical cancer: comparison with SCC and CEA. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/26d9baf973907a54e3ab94697b7c0d6e648f2245/2-TableI-1.png)
Table I from CYFRA 21.1 in patients with cervical cancer: comparison with SCC and CEA. | Semantic Scholar
![Discovery and validation of FBLN1 and ANT3 as potential biomarkers for early detection of cervical cancer | Cancer Cell International | Full Text Discovery and validation of FBLN1 and ANT3 as potential biomarkers for early detection of cervical cancer | Cancer Cell International | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12935-021-01802-5/MediaObjects/12935_2021_1802_Fig1_HTML.png)
Discovery and validation of FBLN1 and ANT3 as potential biomarkers for early detection of cervical cancer | Cancer Cell International | Full Text
![Nucleic acids and proteins carried by exosomes of different origins as potential biomarkers for gynecologic cancers: Molecular Therapy - Oncolytics Nucleic acids and proteins carried by exosomes of different origins as potential biomarkers for gynecologic cancers: Molecular Therapy - Oncolytics](https://www.cell.com/cms/attachment/3e6d9fdf-2cd4-463f-bb34-e5c11fcfa603/fx1_lrg.jpg)
Nucleic acids and proteins carried by exosomes of different origins as potential biomarkers for gynecologic cancers: Molecular Therapy - Oncolytics
![Recent Advances on the Molecular Mechanism of Cervical Carcinogenesis Based on Systems Biology Technologies - ScienceDirect Recent Advances on the Molecular Mechanism of Cervical Carcinogenesis Based on Systems Biology Technologies - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2001037018303301-gr1.jpg)
Recent Advances on the Molecular Mechanism of Cervical Carcinogenesis Based on Systems Biology Technologies - ScienceDirect
![Clinical applications and utility of cell-free DNA-based liquid biopsy analyses in cervical cancer and its precursor lesions | British Journal of Cancer Clinical applications and utility of cell-free DNA-based liquid biopsy analyses in cervical cancer and its precursor lesions | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-022-01868-6/MediaObjects/41416_2022_1868_Fig1_HTML.png)
Clinical applications and utility of cell-free DNA-based liquid biopsy analyses in cervical cancer and its precursor lesions | British Journal of Cancer
![First Study of Oral Artenimol-R in Advanced Cervical Cancer: Clinical Benefit, Tolerability and Tumor Markers | Anticancer Research First Study of Oral Artenimol-R in Advanced Cervical Cancer: Clinical Benefit, Tolerability and Tumor Markers | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/31/12/4417/F1.large.jpg)